Traumatic brain injury-related attention deficits: Treatment outcomes with lisdexamfetamine dimesylate (Vyvanse)

References

• Kraus JF, MacArthur DL. Epidemiologic aspects of brain injury. Neurologic Clinics 1996;14:435–450
   PubMed Web of Science ®Google Scholar
• Moscato BS, Trevisian M, Willer B. The prevalence of traumatic brain injury and co-occurring disabilities in a national household survey of adults. Journal of Neuropsychiatry 1994;6:134–142
   PubMed Web of Science ®Google Scholar
• Levin H, Hanten G, Max J, Li X, Swank P, Ewing-Cobbs L, Dennis M, Menefee DS, Schachar R. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children. Journal of Developmental Behavioral Pediatrics 2007;28:108–118
   PubMed Web of Science ®Google Scholar
• Max JE, Schachar RJ, Levin HS, Ewing-Cobbs L, Chapman SB, Dennis M, Saunders A, Landis J. Predictors of attention-deficit/hyperactivity disorder within 6 months after pediatric traumatic brain injury. Journal of the American Academy of Child and Adolescent Psychiatry 2005;44:1032–1040
   PubMed Web of Science ®Google Scholar
• Max JE, Schachar RJ, Levin HS, Ewing-Cobbs L, Chapman SB, Dennis M, Saunders A, Landis J. Predictors of secondary attention-deficit/hyperactivity disorder in children and adolescents 6 to 24 months after traumatic brain injury. Journal of the American Academy of Child and Adolescent Psychiatry 2005;44:1041–1049
   PubMed Web of Science ®Google Scholar
• Yeates KO, Armstrong K, Janusz J, Taylor HG, Wade S, Stancin T, Drotar D. Long-term attention problems in children with traumatic brain injury. Journal of the American Academy of Child and Adolescent Psychiatry 2005;44:574–584
   PubMed Web of Science ®Google Scholar
• Mirsky A, Anthony B, Duncan C, Ahearn M, Kellam S. Analysis of the elements of attention: A neuropsychological approach. Neuropsychology Review 1991;2:109–145
   PubMedGoogle Scholar
• Kramer ME, Chiu CY, Walz NC, Holland SK, Yuan W, Karunanayaka P, Wade SL. Long-term neural processing of attention following early childhood traumatic brain injury: fMRI and neurobehavioral outcomes. Journal of the International Neuropsychological Society 2008;14:424–435
   PubMed Web of Science ®Google Scholar
• Bush G, Frazier J, Rauch S, Seidman L, Whalen P, Jenike M, Rosen F, Biederman J. Anterior cingulated cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting stroop. Biological Psychiatry 1999;45:1542–1552
   PubMed Web of Science ®Google Scholar
• Bates G. Medication in the treatment of the behavioral sequelae of traumatic brain injury. Behavioral Medicine and Child Neurology 2006;48:697–701
   PubMed Web of Science ®Google Scholar
• Mahalick DM, Carmel PW, Greenberg JP, Molofsky W, Brown JA, Heary RF, Marks D, Zampelia E, Hodosh R, von der Schmidt E. Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatric Neurosurgery 1998;29:121–126
   PubMed Web of Science ®Google Scholar
• Whyte J, Hart T, Schuster K, Fleming M, Polansky M, Coslett HB. Effects of methylphenidate on attention functions after traumatic brain injury: A randomized, placebo-controlled trial. American Journal of Physical Medicine & Rehabilitation 1997;76:440–450
   PubMed Web of Science ®Google Scholar
• Whyte J, Hart T, Vaccaro M, Grieb-Neff P, Risser A, Polansky M, Coslett HB. Effects of methylphenidate on attention deficits after traumatic brain injury: A multidimensional, randomized, controlled trial. American Journal of Physical Medicine & Rehabilitation 2004;83:401–420
   PubMed Web of Science ®Google Scholar
• Schachar R. Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: A critical appraisal of treatment studies. CNS Spectrums 2004;9:217–226
   PubMedGoogle Scholar
• Frenette A, Kanji S, Rees L, Williamson D, Perreault M, Turgeon A, Bernard F, Fergusson D. Efficacy and safety of dopamine agonists in traumatic brain injury: A systematic review of randomized controlled trials. Journal of Neurotrauma 2012;29:1–18
   PubMedGoogle Scholar
• Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, et al. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Archives of General Psychiatry 2008;65:102–114
   PubMed Web of Science ®Google Scholar
• Bales JW, Kline AE, Wagner AK, Dixon CE. Targeting dopamine in acute traumatic brain injury. The Open Drug Discovery Journal 2010;2:119–128
   PubMedGoogle Scholar
• Willmott C, Ponsford J. Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: A randomized, crossover, double blind, placebo controlled inpatient trial. Journal of Neurology, Neurosurgery and Psychiatry 2009;80:552–557
   PubMed Web of Science ®Google Scholar
• Adler L, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry 2008;69:1364–1373
   PubMed Web of Science ®Google Scholar
• Brams M. Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: Randomized withdrawal design. Journal of Clinical Psychiatry 2012;73:977–983
   PubMed Web of Science ®Google Scholar
• Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase lll, multicentre, randomized, double-blind, forced-dose, parallel-group study. Clinical Therapy 2007;29:450–463
   PubMed Web of Science ®Google Scholar
• Coghill D, Banaschewski T, Lecendreux M, Soutullo C, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Lyne A, et al. European, randomized, phase III study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. European Neuropsychopharmacology 2013;23:1208–1218
   PubMed Web of Science ®Google Scholar
• Findling RL, Childress AC, Cutler AJ, Gasior M, Hamdani M, Ferreira-Cornwell MC, Squires L. Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2011;50:395–405
   PubMed Web of Science ®Google Scholar
• Wigal SB, Kollins SH, Childress AC, Squires L. A 13-hour laboratory school study of lisdexamfetamine dimesylate in school aged children with attention-deficit/hyperactivity disorder. Child & Adolescent Psychiatry & Mental Health 2009;3:1–15
   PubMedGoogle Scholar
• Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: Novel findings using a simulated adult workplace environment design. Behavioral and Brain Functions 2010;6:1–14
   PubMedGoogle Scholar
• Barkley RA, Murphy KR. Attention-deficit hyperactivity disorder: A clinical workbook. 2nd ed. New York: The Guilford Press; 1998
   Google Scholar
• Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. 3rd ed. New York: Oxford University Press; 2006
   Google Scholar
• Bush G, Shin LM. The multi-source interference task: An fMRI task that reliably activates the cingulo-frontal-parietal cognitive/attention network. Nature Protocols 2006;1:306–313
   Google Scholar
• Overtoom CCE, Verbaten MN, Kemner C, Kenemans JL, Engeland HV, Buitelaar JK, Van Der Molen MW, Van Der Gugten J, Westenberg H, Maes RAA, Koelega HS. Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with attention deficit hyperactivity disorder. Behavioural Brain Research 2003;145:7--15
   Google Scholar